What was once a metro Atlanta restaurateur's modest tribute to her late mother has become a multi-million-dollar philanthropy ...
In a small pilot study of patients with advanced pancreatic cancer, early access to medical cannabis shows promise in the ...
MedPage Today on MSN
Targeted Drug for Advanced Pancreatic Cancer Sparks Early Enthusiasm
SAN FRANCISCO -- Almost 80% of patients with heavily pretreated advanced/metastatic pancreatic cancer achieved disease ...
9hon MSN
Researchers reveal interplay between chronic pancreatic inflammation and early cancer development
Pancreatic cancer is a rare disease; however, its initially inconspicuous symptoms and aggressive nature make it one of the ...
Pancreatic ductal adenocarcinoma (PDAC) is the most common type of pancreatic cancer and begins in the cells lining the ...
Study Finds on MSN
Scientists Discover Early Gene Change in Pancreatic Cancer
Gene that drops early in pancreatic tumors linked to shorter survival at stage II. Findings could guide future treatment ...
Dr. Benjamin Jon Golas of Hackensack Meridian Health discussed the main strategies for treating pancreas cancer, focusing on ...
Pancreatic cancer uses a sugar-coated disguise to evade the immune system, helping explain why it’s so hard to treat.
Pancreatic Cancer Action Network Calls for Immediate, Sustained Investment in Research Toward Early Detection and Treatment ...
Pancreatic cancer is notoriously hard to treat, often resisting therapies that target its most common mutations. Researchers ...
News-Medical.Net on MSN
CTDNEP1 identified as potential tumor suppressor in pancreatic ductal adenocarcinoma
Pancreatic ductal adenocarcinoma (PDAC) is the most common type of pancreatic cancer and begins in the cells lining the pancreatic duct.
Researchers hope to improve survival rates through early detection with a blood test that can detect over 50 types of cancer.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results